| scholarly article | Q13442814 |
| P50 | author | Gad Rennert | Q67945506 |
| P2093 | author name string | Laura S Rozek | |
| Stephen B Gruber | |||
| Lynn P Tomsho | |||
| Joel K Greenson | |||
| Hedy S Rennert | |||
| Stephanie L Schmit | |||
| P2860 | cites work | Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity | Q24800999 |
| Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis | Q27024810 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Statins and the risk of colorectal cancer | Q28176056 | ||
| Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival | Q28277824 | ||
| Aspirin use and survival after diagnosis of colorectal cancer | Q33764480 | ||
| Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer | Q33930691 | ||
| Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study | Q34102606 | ||
| The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis | Q34188723 | ||
| Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review | Q34551974 | ||
| Association between molecular subtypes of colorectal cancer and patient survival | Q34759064 | ||
| Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations. | Q34985439 | ||
| Histopathological identification of colon cancer with microsatellite instability | Q35746344 | ||
| High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability | Q35787046 | ||
| Lymphoid infiltration and prognosis in colorectal carcinoma | Q35991423 | ||
| Primary tumor location as a prognostic factor in metastatic colorectal cancer. | Q36047405 | ||
| MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers | Q36123830 | ||
| Pathologic predictors of microsatellite instability in colorectal cancer | Q36404900 | ||
| Classification of colorectal cancer based on correlation of clinical, morphological and molecular features | Q36699559 | ||
| Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy | Q37161846 | ||
| Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype | Q37407802 | ||
| Genetic prognostic and predictive markers in colorectal cancer | Q37523207 | ||
| Cigarette smoking and colorectal cancer mortality among 602,242 Norwegian males and females | Q37698626 | ||
| Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer | Q38423068 | ||
| Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma | Q40620362 | ||
| The immune score as a new possible approach for the classification of cancer | Q42539190 | ||
| Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. | Q44274945 | ||
| Characteristics and significance of colorectal cancer associated lymphoid reaction | Q45027953 | ||
| The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration | Q47809942 | ||
| Distinct molecular features of colorectal cancer in ghana | Q50781061 | ||
| The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases | Q52641814 | ||
| Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator | Q68837115 | ||
| Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis | Q72410053 | ||
| Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability | Q73322611 | ||
| Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer | Q73828602 | ||
| Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma | Q74046178 | ||
| Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic | Q79834699 | ||
| Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity | Q83602657 | ||
| Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator in colon cancer | Q84071326 | ||
| The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus | Q95383722 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| P577 | publication date | 2016-05-12 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer | |
| P478 | volume | 108 |
| Q89867704 | A Rare Case of Moderately Differentiated Adenocarcinoma With PD-L1 Overexpression and a Heterogeneous LELC Component in the Ascending Colon |
| Q42396426 | Additional Support for the Introduction of Immune Cell Quantification in Colorectal Cancer Classification |
| Q90208674 | An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer |
| Q90277667 | Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance) |
| Q36345775 | Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. |
| Q46540302 | Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca |
| Q40060444 | Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor. |
| Q64917271 | Associations among histological characteristics and patient outcomes in colorectal carcinoma with a mucinous component. |
| Q38761014 | Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study. |
| Q33808553 | Biomarker correlation network in colorectal carcinoma by tumor anatomic location |
| Q99580038 | CD8+ tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival |
| Q92795256 | Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene Status |
| Q64123101 | Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis |
| Q95822367 | Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer |
| Q50332434 | Deep learning based tissue analysis predicts outcome in colorectal cancer |
| Q48307824 | Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis. |
| Q90612132 | Impact of tumor infiltrating lymphocytes and lymphoid follicle formation on patient survival following surgery for lung squamous cell carcinoma |
| Q62494554 | Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology |
| Q53601791 | Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. |
| Q50043586 | Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine |
| Q57288172 | Inter-tumoral heterogeneity of CD3 and CD8 T-cell densities in the microenvironment of DNA mismatch repair-deficient colon cancers: implications for prognosis |
| Q39294187 | MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer |
| Q48249876 | Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma |
| Q91646491 | Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells |
| Q64999952 | Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer. |
| Q64930888 | Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers. |
| Q90084293 | Prognosticators of Long-Term Outcomes of TNM Stage II Colorectal Cancer: Molecular Patterns or Clinicopathological Features |
| Q50111084 | Prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2), a complex target for colorectal cancer prevention and therapy |
| Q58704497 | Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer |
| Q104499981 | Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer |
| Q57476251 | Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells |
| Q36405971 | Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas |
| Q52320729 | Strategy to targeting the immune resistance and novel therapy in colorectal cancer |
| Q51135353 | T-Cell Transfer Therapy Targeting Mutant KRAS. |
| Q37736897 | TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells. |
| Q89097041 | TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas |
| Q90050585 | The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer |
| Q89882588 | The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis |
| Q38638847 | The colorectal cancer immune microenvironment and approach to immunotherapies. |
| Q47192478 | The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC). |
| Q55424174 | Treatment of Elderly Patients with Colorectal Cancer. |
| Q50077322 | Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer. |
| Q55250651 | Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality. |
| Q89665024 | Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation |
| Q51045025 | Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer |
Search more.